MetLife (NYSE:MET), the leading life insurance company with a 'Strong Buy' status, has been showing consistent growth. Despite market challenges, MetLife has seen 11.4% and 18.2% growth over three and six months, respectively. Q3 Earnings surpassed estimates and Q1 Earnings met the expected values. The S&P500 stock has a new price target of $86.00 set by Keefe, Bruyette & Woods and, was later revised to $82.00 at Piper Sandler. The dividend, a selling point for MET, has grown from last year. Technology has also been a focus with the launch of a pet health and wellness app in partnership with Microsoft, and a savings calculator for pet parents. Negative news includes the sale of 920 MET shares by Merit Financial Group and MetLife Stadium's reconfiguration for the World Cup. However, their stock has generally shown signs of growth.
Metlife MET News Analytics from Thu, 03 Aug 2023 07:00:00 GMT to Fri, 10 May 2024 06:03:46 GMT -
Rating 7
- Innovation 3
- Information 9
- Rumor -2
